Assessing the incidence of acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy compared to that of vancomycin and cefepime
Crossref DOI link: https://doi.org/10.30574/ijsra.2021.2.1.0040
Published Online: 2021-03-30
Update policy: https://doi.org/10.30574/ijsra.ourcrossmarkpolicy
Sydney Jean Rechtenbaugh,
Fekadu Fullas,
Kimberly Ann Zellmer,
Joseph Michael Buren,
Corey James Thieman,
Michael Theodore Padomek,
